Peanut Protein Powder for Surgery

Auburn University, Auburn, AL
SurgeryPeanut Protein Powder - DietarySupplement
60 - 75
All Sexes

Study Summary

This trial will study the effects of peanut protein on muscle size and quality in patients undergoing knee surgery.

Eligible Conditions
  • Surgery

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

2 Primary · 5 Secondary · Reporting Duration: 0-6 weeks, 6-12 weeks

0-6 weeks, 6-12 weeks
Change in inflammatory biomarkers
Change in leg extensor isokinetic dynamometry
Change in mid-thigh skeletal muscle area
Change in mid-thigh skeletal muscle area and quality
Oxford Knee Score
Physical Function testing
Physical Performance testing

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Wait-llist Control Group
1 of 2
Immediate Intervention Group
1 of 2

Active Control

Experimental Treatment

1 Total Participants · 2 Treatment Groups

Primary Treatment: Peanut Protein Powder · No Placebo Group · N/A

Immediate Intervention GroupExperimental Group · 2 Interventions: Standard Care by Surgeon and Physical Therapist, Peanut Protein Powder · Intervention Types: Other, DietarySupplement
Wait-llist Control Group
ActiveComparator Group · 1 Intervention: Standard Care by Surgeon and Physical Therapist · Intervention Types: Other
First Studied
Drug Approval Stage
How many patients have taken this drug
Peanut Protein Powder

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 0-6 weeks, 6-12 weeks

Who is running the clinical trial?

Auburn UniversityLead Sponsor
59 Previous Clinical Trials
13,918 Total Patients Enrolled
Edward Via College of Osteopathic Medicine-AuburnUNKNOWN
1 Previous Clinical Trials
56 Total Patients Enrolled
Jack Hughston Memorial HospitalUNKNOWN
Randall J Ruark, MDStudy ChairJack Hughston Memorial Hospital

Eligibility Criteria

Age 60 - 75 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Is enrollment into this experiment available to the public?

" asserts that this experiment is still recruiting participants, having been first advertised on August 1st 2021 and most recently revised April 12th 2022." - Anonymous Online Contributor

Unverified Answer

Is there an opportunity for me to participate in this investigation?

"This trial is willing to consider 30 individuals who suffer from muscular atrophy and are between 60-75 years of age. Notably, the following conditions must be met: they have a total knee arthroplasty scheduled in two weeks or less under the supervision of doctors at Jack Hughston Clinic." - Anonymous Online Contributor

Unverified Answer

What are the main goals of this trial?

"The primary purpose of the study, evaluated over a two-month period is to assess changes in mid-thigh skeletal muscle area and quality. Secondary objectives include gauging change in leg extensor isokinetic dynamometry using a BioDex device, physical performance testing utilising the 2 minute walk test, as well as measuring changes in serum C-reactive protein, interleukin 6 levels, tumor necrosis factor alpha concentrations and plasma 8 hydroxy 2’deoxyguanosine measurements." - Anonymous Online Contributor

Unverified Answer

What is the current participation rate for this research?

"Affirmative. According to the information available on, recruitment for this medical trial is still in progress since it was first posted on August 1st 2021 and last updated April 12th 2022. The researchers are looking to include up to 30 patients at one site." - Anonymous Online Contributor

Unverified Answer

Does this clinical trial allow for enrolment of participants above the age of 85?

"The eligibility requirements of this medical study necessitate that the participants be between 60 and 75 years old." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.